Welcome and introduction Chair – Souha Kanj (Lebanon) ESCMID-appointed Chair – Cansu Cimen (Netherlands) |
|
|
Lessons from history when tackling adversity Erica Charters (UK) |
|
|
SARS-CoV-2 Variants: epidemiology and transmission Souha Kanj (Lebanon) |
|
|
Pathogenesis of COVID-19: the role of the virus Alex Soriano (Spain) |
|
|
|
Summary and close Chair – Souha Kanj (Lebanon) ESCMID-appointed Chair – Cansu Cimen (Netherlands) |
|
|
|
Saturday 10 July, 2021, 16:15–18:15 CEST |
Piecing together the patient puzzle: navigating the MDR Gram-negative infection treatment paradigm |
|
|
Welcome and introduction Chair – Christian Eckmann (Germany) ESCMID-appointed Chair – William Hope (UK) |
|
|
Optimising the management of MDR Gram-negative infection: early versus late treatment Michele Bartoletti (Italy) |
|
|
A spotlight on MDR Pseudomonas aeruginosa: what do the data tell us? Juan-Pablo Horcajada (Spain) |
|
|
Tackling priority pathogens: the challenge of CRE Ana Gales (Brazil) |
|
|
Real-world use of ceftazidime‒avibactam*: data from the last four years Mario Tumbarello (Italy) |
|
|
Exploring the options: novel therapies and recommendations for MDR Gram-negative infection Christian Eckmann (Germany)
|
|
|
Panel discussion and Q&A All |
|
|
Reflection points and close Chair – Christian Eckmann (Germany) ESCMID-appointed Chair – William Hope (UK) |
|
|
|
Sunday 11 July, 2021, 13:15–15:15 CEST |
Treating invasive mould disease in an era of complex epidemiology and patient needs |
|
|
Welcome and introduction Chair – Johan Maertens (Belgium) ESCMID-appointed Chair – Ferry Hagen (Netherlands) |
|
|
Invasive mould disease and COVID-19: what do we need to know? Alexandre Alanio (France) |
|
|
The diagnostic-driven approach to invasive mould disease in times of medical uncertainty Johan Maertens (Belgium) |
|
|
PK/PD considerations and hot topics in antifungal treatment Roger Bruggemann (Netherlands) |
|
|
Best-practice approach to the management of invasive mould infections in patients with severe comorbidities: a case study Malgorzata Mikulska (Italy) |
|
|
Discussion, Q&A and close All |
|
|
|
Sunday 11 July, 2021, 16:15–18:15 CEST |
What are the treatment options for CAP and cSSTI in 2021? |
|
|
Introduction Chair – Philippe Montravers (France) ESCMID-appointed Chair – Gian Maria Rossolini (Italy) |
|
|
Can we help improve AMS for CAP and cSSTI in the wake of COVID-19? Roman Kozlov (Russia) |
|
|
How do we manage CAP patients? Antoni Torres (Spain) |
|
|
The paediatric pneumonia patient Susanna Esposito (Italy) |
|
|
Recommendations for the treatment of cSSTI Philippe Montravers (France) |
|
|
|
Close Chair – Philippe Montravers (France) ESCMID-appointed Chair – Gian Maria Rossolini (Italy) |
|
|